XML 58 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Share Options (Tables)
12 Months Ended
Dec. 31, 2022
Share Options [Abstract]  
Schedule of company’s share option activity for employees and members of the board of directors
    Number of
Share
Options
    Weighted
Average
Exercise
Price
$
    Weighted
average
remaining
contractual
life (years)
    Intrinsic
value
$
 
Outstanding as of December 31, 2019     1,291,810       1.65       5.94       194  
Granted     353,960       1.80       9.35          
Exercised     (9,800 )     1.15      
-
         
Forfeited or expired     (381,970 )     1.75      
-
         
Outstanding as of December 31, 2020     1,254,000       1.70       6.12       125  
Exercisable as of December 31, 2020     839,665       1.50       4.73       252  

 

    Number of
Share
Options
    Weighted
Average
Exercise
Price
$
    Weighted
average
remaining
contractual
life (years)
    Intrinsic
value
$
 
Outstanding as of December 31, 2020     1,254,000       1.70       6.12       125  
Granted     214,688       2.05       9.64          
Forfeited or expired     (101,520 )     1.80      
-
         
Outstanding as of December 31, 2021     1,367,168       1.75       5.72       4,860  
Exercisable as of December 31, 2021     927,988       1.60       4.25       3,429  

 

    Number of
Share
Options
    Weighted
Average
Exercise
Price
$
    Weighted
average
remaining
contractual
life (years)
    Intrinsic
value
$
 
Outstanding as of December 31, 2021     1,367,168       1.75       5.72       4,860  
Granted     286,875       1.83                  
Forfeited or expired     (83,052 )     1.45       -          
Outstanding as of December 31, 2022     1,570,991       1.78       4.97       2,435  
Exercisable as of December 31, 2022     1,048,297       1.70       3.2       1,677  

 

Schedule of outstanding and exercisable share options separated ranges of exercise prices
Exercise price   Share options
outstanding
as of
December 31,
2022
    Weighted
average
remaining
contractual
term (years)
    Share options
exercisable
as of
December 31,
2022
    Weighted
average
remaining
contractual
term (years)
 
$         $           $  
0.00     152,640       2.42       152,640       1.03  
1.14     228,480       1.39       228,480       1.39  
1.67     43,200       2.21       43,200       2.21  
1.83     982,870       6.75       489,239       4.70  
3.2     35,001       6.45       10,938       6.45  
3.79     60,000       1.59       60,000       1.59  
4.17     28,800       3.03       28,800       3.03  
5.12     40,000       6.54       35,000       6.54  
      1,570,991               1,048,297          

 

Schedule of assumptions used to estimate the fair values of the share options granted
    Year ended December 31  
    2022     2021     2020  
                   
Volatility (%)     61.49 %     64.75 %     61.89%-61.91 %
Risk-free interest rate (%)     3.64%-3.85 %     0.09 %     0.03%-0.04 %
Dividend yield (%)     -       -       -  
Expected life (years)     6.25       6.25       6.25  
Exercise price ($)     1.83       1.80-3.20       1.80  
Share price ($)     3.30       3.20       1.80  

 

Schedule of company’s equity-based awards recognized
    Year ended December 31  
    2022     2021     2020  
                   
Research and development   $ 144     $ 94     $ 60  
Sales and marketing     49       45       48  
General and administrative     29       18       12  
    $ 222     $ 157     $ 120